October · Topic 5 of 19

Oropharynx

OropharynxWeek 2Oct 14, 2026

Oropharyngeal Cancer: Staging, Systemic Therapy and De-escalation Trials

Staging as a survival prediction tool from ICON-S to AJCC 8th edition, why cisplatin is still the standard, the NRG HN002 and HN005 de-escalation trials, and where de-escalation goes next.

Read the email

OropharynxWeek 1Oct 7, 2026

Oropharyngeal Cancer: HPV and Epidemiology

How HPV came to be recognised as a cause of head and neck cancer, why surgical and chemoradiation cohorts agree on its better prognosis, why p16 and HPV testing are not quite the same thing, and why vaccination works but slowly.

Read the email